NIBEC Co., Ltd. (KOSDAQ:138610)

South Korea flag South Korea · Delayed Price · Currency is KRW
40,150
-1,850 (-4.40%)
At close: Dec 5, 2025
148.61%
Market Cap 456.18B
Revenue (ttm) 32.96B
Net Income (ttm) 3.11B
Shares Out 11.36M
EPS (ttm) n/a
PE Ratio 146.51
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 166,511
Average Volume 203,235
Open 41,800
Previous Close 42,000
Day's Range 39,450 - 42,050
52-Week Range 12,800 - 48,200
Beta 0.86
RSI 53.22
Earnings Date Aug 14, 2025

About NIBEC

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is headquartered in Jincheon-eup, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 96
Stock Exchange KOSDAQ
Ticker Symbol 138610
Full Company Profile

Financial Performance

In 2024, NIBEC's revenue was 24.55 billion, an increase of 56.33% compared to the previous year's 15.70 billion. Losses were -9.33 billion, 48.4% more than in 2023.

Financial Statements

News

There is no news available yet.